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Enantioselective cellular localisation of
europium(III) coordination complexes†
Andrew T. Frawley, Holly V. Linford, Matthieu Starck, Robert Pal
and David Parker *
The selective mitochondrial localisation of the L enantiomer of three diﬀerent emissive europium(III)
complexes in NIH 3T3 and MCF7 cells contrasts with the behaviour of the D enantiomer, for which
a predominant lysosomal localisation was observed by confocal microscopy. In each case, cell uptake
occurs via macropinocytosis.
Introduction
Europium(III) complexes have been used extensively as stains for
live cell uorescence microscopy.1 The development of
responsive probes has allowed emissive europium(III)
complexes to be used to measure the intracellular concentra-
tions of a number of biologically relevant molecules, in addition
to pH and pO2.2 Of critical importance for intracellular stains
and probes, is the mechanism of uptake. In order for a complex
to be used in cellulo, a comprehensive understanding of cell
uptake and sub-cellular localisation is required to aid in the
design of new probes to target particular organelles. Whilst the
cell uptake mechanism of a wide range of 12-N4 based systems
has been studied,3 a thorough investigation of the mechanism
of internalisation of the EuroTracker™ 9-N3 based systems with
pyridylarylalkynyl chromophores has not been undertaken. A
preliminary investigation suggested that macropinocytosis was
involved in the uptake of these complexes, but the presence of
other competing mechanisms was not ruled out.1a,4
Here we report on the eﬀect of probe chirality on the uptake
process. Detailed studies of enantioselective behaviour in living
cells have not been reported before. Since recognition in bio-
logical systems generally involves chiral proteins and glyco-
conjugates, the uptake of chiral probe species is expected to
display chiral discrimination,5a due to diﬀerential diastereo-
isomeric interactions. Indeed, chiral discrimination of such
complexes by sugars has been demonstrated in the resolution of
the enantiomers by chiral HPLC with polysaccharide chiral
stationary phases.5b Similarly, if the sub-cellular transport of the
complexes is regulated by proteins, then variation in the
localisation of the enantiomers and their rate of transfer inside
the cell may also be aﬀected.
The complexes chosen for this study, [EuL1–3], were selected
as they met the following key selection criteria: solubility in
water; excitation around 355 to 365 nm with a brightness of the
order of 10 to 25 mM1 cm1 at these wavelengths; good pho-
tostability to pulsed excitation; a propensity to be taken into
cells.
Results and discussion
A cell uptake study was initially carried out using racemic
[EuL2], which has already been demonstrated to be taken into
cells,6 in order to establish the mechanism by which internal-
isation occurs. Secondly, the uptake and sub-cellular local-
isation of the enantiomers of [EuL1–3] were investigated, drawn
here as the S-D enantiomers.
The synthesis of each complex used reported routes.6 Full
synthetic details and characterisation for [EuL3] can be found in
the ESI.† The cell uptake behaviour of [EuL2] was investigated in
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NIH-3T3 cells (mouse skin broblasts) in the presence of
various promoters and inhibitors of macropinocytosis, clathrin-
mediated endocytosis and caveolae-mediated endocytosis.3 For
cell uptake experiments, the cells were incubated for 30minutes
in growth medium containing the promoters and inhibitors
shown in Scheme 1. Cells were washed and incubated with
growth medium containing [EuL2] (30 mM) and the promoters/
inhibitors. Aer 4 hours, the coverslips were removed, washed
with growth medium and mounted on glass slides.
A control sample was produced using identical procedures,
without the addition of promoters or inhibitors. Laser scanning
confocal microscopy images were recorded using pulsed exci-
tation at 355 nm.7 The extent of complex internalisation was
measured by analysis of the brightness of the acquired images.
In each case, the image brightness in the 605–720 nm emission
range of several perinuclear sample areas from each cell was
recorded. This was repeated for multiple cells. Overall, at least
45 sample areas from multiple cells were recorded per treat-
ment. The mean value was taken for each result and compared
to the image brightness recorded using the samemethod for the
control sample. Earlier work has shown that comparative image
brightness measurements in such experiments gave values that
were very similar to independent measurements of europium
concentration using inductively coupled plasma mass spec-
trometry (ICP-MS).
It is immediately evident (Fig. 1) that 1,2-dipalmitoyl-rac-
diacylglycerol (Di-Rac), a fatty acid glycerol and known
promoter of macropinocytosis, signicantly enhances the
uptake of [EuL2]. Aer treatment of the cells with amiloride and
wortmannin, both inhibitors of macropinocytosis, the inter-
nalisation of [EuL2] is reduced by about 40%, compared to the
control. Similarly, for cells incubated at low temperature, the
uptake of complexes is reduced, although low temperature is
expected to inhibit such endocytotic pathways. Such behaviour
does, however, conrm that uptake is via an active process. The
promoters and inhibitors of other pathways do not have
signicant eﬀects on the internalisation of the complex,
consistent with the behaviour observed for a large series of 12-
N4 based Eu(III) complexes. Conspicuously, on treatment of the
cells with a phorbol ester (phorbol 12-myristate 13-acetate),
which is known to stimulate macropinocytosis, the brightness
of the complex in the cells is reduced by approximately 30%,
relative to the control. In order to assess whether the phorbol
ester was quenching the [EuL2] emission and causing this
anomalous result, emission spectra were recorded in cell lysate
in the presence and absence of the phorbol ester. In its pres-
ence, the emission intensity was quenched by approximately
35% without much change in emission lifetime (1.11 vs.
1.06 ms). Such behaviour is consistent with reduced absorption
eﬃciency or energy transfer to the metal, rather than quenching
of the metal excited state. Whilst a 35% quenching eﬀect may
initially appear to account for the 30% reduced brightness in
microscopy, one cannot assume that the relative concentration
of the complex and the phorbol ester is the same in cellulo as it
is in vitro. However, it does provide evidence that such
a quenching process may account for the lower than expected
emission observed for this complex by microscopy.
Taking into account all the data, it seems highly likely that
macropinocytosis is the primary route of uptake of [EuL2]. Since
this is a non-selective pathway, such results combined with
those acquired in the preliminary study for complexes with
similar structures, suggest that macropinocytosis is the primary
route of uptake for this class of compounds. Previous work on
12-N4 complexes concluded that simultaneous passive uptake
was unlikely, as complexes of diﬀerent hydrophilicity (by
comparison of octanol–water partition coeﬃcients) did not
show any variation in cell uptake.3 As the uptake of anionic,
cationic and neutral complexes was aﬀected similarly by
promoters and inhibitors of macropinocytosis, it is reasonable
to assume that variations in charge and hydrophilicity do not
Scheme 1 Schematic illustration of three possible endocytotic path-
ways for the uptake of lanthanide complexes, and the maturation of
endosome to lysosomes. In red are known activators (denoted with
a +) and inhibitors () of each process.
Fig. 1 Mean relative brightness of europium(III) emission from cells
incubated with [EuL2] after treatment with promoters and inhibitors of
various cell uptakemechanisms. Inhibitors (red) and promoters (green)
of macropinocytosis are highlighted. Results which have statistical
signiﬁcance (two-tailed Student's t-test at 95% conﬁdence) are
marked *. Error bars represent one standard deviation from the mean.
This journal is © The Royal Society of Chemistry 2018 Chem. Sci., 2018, 9, 1042–1049 | 1043
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aﬀect the uptake mechanism, across a series of otherwise
structurally similar complexes.
Unlike receptor-mediated endocytosis, which is activated by
binding of a specic substrate to a specic cell surface receptor,
macropinocytosis is a non-selective uptake mechanism. It
occurs in response to stimulation of receptor tyrosine kinases,8
which are trans-membrane proteins capable of up-regulating
actin polymerisation. It is the increase of actin polymerisation
that is responsible for the formation of membrane ruﬄing.
Occasionally, the membrane ruﬄes fold back on themselves,
forming macropinosomes. These macropinosomes are large
(>0.2 mm diameter and up to 5 mm in some examples)9,10
compared to other endocytotic vesicles (e.g. clathrin-coated
vesicles are approximately 100 nm in diameter),11 meaning
a large volume of extracellular uid is internalised.
It has been observed that the fate of macropinosomes varies
in diﬀerent cell types. In epithelial and broblast cells which are
growth factor stimulated, macropinosomes remain relatively
isolated from the endo-lysosomal system and eventually fuse
back with the cell membrane.10 Such an observation is consis-
tent with the need for these types of cells to constantly reor-
ganise the plasmamembrane in response to external stimuli. In
contrast, in cells where degradation of extracellular material is
key (such as renal cells and macrophages), macropinosomes
fuse with late endosomes and lysosomes.12
Eﬀect of chirality on cell uptake and
sub-cellular localisation
Although macropinocytosis is a non-specic mechanism of
internalisation, the possibility of chirality dependent cell
uptake and sub-cellular localisation is not precluded. For
instance, favourable interaction of one enantiomer of complex
with a protein or other substrate in the extracellular environ-
ment which can stimulate membrane ruﬄing, may result in one
enantiomer being internalised more than the other. The fate of
the complex once internalised may also involve transport by
protein. Since proteins possess chiral binding pockets, it is
possible that diﬀerent sub-cellular localisations may be
observed for diﬀerent enantiomers.
An understanding of such behaviour is crucial in the use of
emissive stains and probes in live cell imaging, both for chiral
complexes and achiral complexes which may exhibit induced
chirality on binding. Since complex [EuL2] has already been
reported as a stain for live cell imaging,1a and it is simple to
resolve the enantiomers by chiral HPLC, it was a logical choice
for such an investigation. Additionally, parallel experiments
were carried out with [EuL1] under the same conditions to
ascertain whether the nature of the chromophore would aﬀect
its uptake or localisation prole.
NIH-3T3 cells were rst treated with racemic [EuL2] and
studied by microscopy. The complex was readily internalised by
the cells and co-staining with MitoTracker Green conrmed
a predominant mitochondrial localisation (P ¼ 0.92) aer 4 h
(ESI†), consistent with the behaviour observed previously for
this complex.1a Although mitochondria are oen illustrated as
‘bean-shaped’ organelles (and oen appear as such in electron
micrographs where cells are xed with heavy metals), in live
cells they are dynamic, with the ability to change their shape as
well as fuse and divide,13 and appear as a tubular network rather
than as distinct organelles. The cell toxicity was checked using
an MTT assay, and conrmed no evidence for impairment of
mitochondrial redox activity using an MTT assay with 100 mM
added complex, aer a 24 h incubation.1a
Cell uptake experiments were repeated with enantiopure D-
and L-[EuL2]. Both NIH-3T3 (mouse skin broblasts) and MCF7
cells (a human breast cancer cell line) were treated with complex
(30 mM and 19 mM respectively) and examined by microscopy in
each case aer a four or 24 h incubation. No signicant changes
in localisation prole were evident aer these diﬀerent incu-
bation times in either case. Comparison of the europium(III)
emission brightness showed that emission from the cells
treated with L-[EuL2] was brighter than from the cells treated
with D-[EuL2] by a factor of two in each cell line. In order to
conrm that uptake of the two enantiomers was diﬀerent, cells
were also prepared for ICP-MS measurements. Cells dosed with
complex were washed with phosphate buﬀered saline to remove
any complex that was not internalised, before being trypsinated
and harvested from the cover slip. Following digestion of the
sample overnight in concentrated nitric acid, ICP-MS was used
to measure the concentration of europium in the sample. This
value was then used to calculate the concentration of europium
in the cell sample. In the case of cells treated with [EuL2], ICP-
MS analysis of a number of NIH 3T3 cell samples showed that
on average there was 1.6 times more L-[EuL2] than D-[EuL2]
internalised, providing further evidence that the L-enantiomer
is preferentially internalised by NIH-3T3 cells.
Initial attempts to carry out the same experiments using D-
and L-[EuL1] resulted in cell images that were signicantly less
bright that those observed for [EuL2], when cells were treated
with the same concentration of complex. However, it was
possible to estimate that the emission from the cells treated
with D-[EuL1] was more intense by approximately 30%. ICP-MS
analysis of these cell samples revealed that 1.7 timesmore of the
D-enantiomer was internalised compared to the L-enantiomer.
The reduced brightness in cells for this complex can be attrib-
uted to self-aggregation leading to quenching of the euro-
pium(III) emission. In water, a reduction in emission lifetime is
observed for [EuL1] at concentrations above 15 mM. Whilst ICP-
MS data suggest that the overall concentration in the cells is not
this high, it is possible that local concentrations in areas where
the complex localises may be similar to this. Additionally, both
enantiomers of [EuL1] were more emissive and possessed
longer-lived excited states in cell growth medium than in water,
suggesting that complex aggregation is suppressed to some
extent in the growth medium. Repeating the cell experiments
with a lower dosing of complex [EuL1] (3 mM) resulted in
signicantly brighter images for both enantiomers than were
acquired at ten times higher loading, conrming that self-
quenching was indeed occurring at higher concentration. In
agreement with the more concentrated treatments, and the ICP-
MS data, the cells treated withD-[EuL1] were brighter than those
treated with L-[EuL1].
1044 | Chem. Sci., 2018, 9, 1042–1049 This journal is © The Royal Society of Chemistry 2018
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Spectral imaging of the complexes in cellulo revealed emis-
sion proles and lifetimes that are consistent with those
observed in vitro, conrming that the europium(III) ion is held
intact within the unperturbed ligand framework (ESI†). It is
evident that in each case, one enantiomer is favourably
internalised. Such behaviour might be explained if one of the
enantiomers is interacting more strongly with a protein and
being internalised whilst bound to protein. In order to test this
hypothesis, each enantiomer of [EuL2] was titrated with bovine
serum albumin (BSA, the most abundant protein in the cell
growth medium). The absorption and emission spectra, as well
as emission lifetimes, were monitored as a function of added
BSA for each enantiomer.
In the absorption spectra, the extinction coeﬃcient of the
chromophore internal charge transfer band of each enantiomer
increased as BSA was added, and for L-[EuL2] a small hyp-
sochromic shi (5 nm) of the absorption maximum was
observed. Such behaviour is consistent with the chromophore
experiencing a less polar environment. The total emission
intensity for each enantiomer increased as a function of added
BSA; a more signicant change in intensity was observed for the
L-enantiomer. The emission lifetime of L-[EuL2] also increased
by approximately 20% as the protein concentration increased,
while the lifetime of the D-enantiomer showed little variation.
An estimate of the binding aﬃnity was made by tting the
variation of an emission intensity ratio with added protein
concentration; values of log K ¼ 5.89 and 5.79 M1 were esti-
mated for the L and D isomers respectively (Fig. 2).
The circularly polarised luminescence (CPL) spectra of the
enantiomers were also recorded as protein was added (ESI†).
The CPL spectrum of L-[EuL2] increased in intensity as protein
was added, consistent with the increased intensity observed in
total emission. The behaviour of D-[EuL2] was more compli-
cated. In the DJ ¼ 4 manifold, a small decrease in CPL intensity
is observed, whilst a signicant decrease in CPL intensity is
evident in the DJ ¼ 1 and 2 manifolds. The DJ ¼ 3 manifold is
largely unaﬀected by protein. If the complex was experiencing
protein-catalysed racemisation, all manifolds would be ex-
pected to lose CPL intensity together.
The increase in emission intensity and lifetime exhibited by
L-[EuL2] with added protein is consistent with the complex
experiencing a less polar environment, reducing the extent of
second sphere quenching by water. In addition, the modulation
of luminescence intensity may be ascribed to a contribution
from suppression of non-radiative deactivation pathways due to
restricted motion in the protein-bound complex. Although D-
[EuL2] does exhibit a small overall increase in emission inten-
sity, the eﬀect is not as signicant as that observed for the L-
enantiomer (ESI†). Such behaviour suggests that the two
enantiomers are not interacting with BSA in the same manner.
L-[EuL2] experiences the slightly stronger interaction with BSA,
and this behaviour may tentatively be linked to why it is
internalised more than D-[EuL2].
Serum albumin possesses a number of distinct binding
pockets of varying structure,14,15 and is known to bind to
a variety of endogenous and exogenous species, including fatty
acids, metal ions, steroids, amino acids and many drugs.16–19 It
is also known to bind to a variety of chelating and macrocyclic
metal complexes used as contrast agents.20–23 Indeed, recent
work has shown that complexes bearing pyridylarylalkynyl
chromophores can bind quite strongly to serum albumin, per-
turbing the energy of the ICT excited state, signalled by
a switching on of europium(III) emission.24
It has been proposed that serum albumin proteins exhibit
non-specic adsorption to cell surface membranes, acting to
protect the cell membrane from physical stress, although this
behaviour seems to originate from physicochemical interactions
as opposed to any biological response.25 Studies of the interac-
tion between BSA and lipid bilayers suggest that BSA adsorbs to
the membrane at low concentrations, but causes disruption and
membrane leakage at higher concentration.26 However, serum
albumins also bind to a number of cell surface receptors, which
vary depending on cell type.27 Binding to cell membranes allows
serum albumins to deliver their cargo directly to target cells. If
the L-[EuL2] enantiomer interacts more strongly with serum
albumin, then it may increase the local concentration of the
complex at the cell membrane, thereby increasing the proba-
bility of internalisation of this particular enantiomer.
Chiral lanthanide(III) complexes have previously been
shown to exhibit diﬀerential binding to BSA.28 The enantiomers
of complexes with tetraazatriphenylene chromophores were
shown to have very diﬀerent behaviour in the presence of BSA,
with the D enantiomer binding to BSA with a 1 : 1 binding
constant of log K ¼ 5.1, while the L-enantiomer formed various
low aﬃnity adducts. Indeed, for the D-enantiomer, there was
a signicant change in CPL spectral form, consistent with
a change in complex helicity upon binding.29 Whilst such
signicant variation in behaviour is not exhibited by [EuL2],
there is a precedent for enantioselective protein binding with
emissive europium(III) complexes.
In addition to studying the relative uptake of the enantio-
mers of [EuL1] and [EuL2], the sub-cellular localisation of the
Fig. 2 Total integrated emission intensity for D- and L-[EuL2] as
a function of added BSA (4 mM complex, 0.1 M HEPES, 0.1 M NaCl, pH
7.40, 295 K, lexc 340 nm, 295 K); the curve shows the ﬁt to the
experimental data, derived by iterative non-linear, least squares ﬁtting.
This journal is © The Royal Society of Chemistry 2018 Chem. Sci., 2018, 9, 1042–1049 | 1045
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enantiomers was also investigated in NIH 3T3 and MCF-7 cells.
As before, the cells were incubated with enantiopure complex
and imaged by laser scanning confocal microscopy. The enan-
tiomers of [EuL2] clearly demonstrated quite diﬀerent local-
isation proles, with no major diﬀerence in this aspect at 4, 8
and 24 h. The L-enantiomer exhibited a predominant mito-
chondrial localisation revealed by the appearance of tubular
networks, (Fig. 3) while the D-enantiomer exhibited a more
lysosomal prole seen as circular dots, notably in the peri-
nuclear region. Both enantiomers also produced some weak
more diﬀuse emission from the cytosol. Co-localisation studies
with MitoTracker Green and LysoTracker Green conrmed
these assumptions. The estimated P values indicating the
degree of co-localisation were 0.77 for the D complex with LTG,
compared to 0.38 with MTG. For the L enantiomer, P values
were 0.29 for LTG and 0.71 with MTG.
In MCF-7 cells the localisation prole of [EuL2] was also
diﬀerent for the two enantioemrs, and did not change signi-
cantly with time. At 4 h, the D-[EuL2] isomer gave P ¼ 0.65 for
correspondence with Lysotracker Green and P¼ 0.38 with MTG;
and for the L enantiomer, P ¼ 0.29 with LTG and P ¼ 0.73 with
MTG. Such behaviour is remarkably similar to that found in
NIH 3T3 cells, (ESI Fig. S9–S12†).
Aer a 24 h incubation, the cells were still alive and exhib-
iting normal cell cycles. Indeed, it is possible to see a cell in the
telophase state of mitosis (le hand panel: Fig. 3), where the
nuclear membranes have reformed, and the cell is about to
undergo cytokinesis, where the cell membrane separates to
form two distinct cells. Similar behaviour was observed for
[EuL1], with the L-enantiomer exhibiting predominant local-
isation in the mitochondrial network aer 24 h, in contrast to
the lysosomal localisation of the D-enantiomer. In order to
quantify the absence of signicant cellular toxicity under these
conditions, an ImageCytometry viability and vitality analysis
was performed on the separated enantiomers of [EuL2] in NIH
3T3 cells. This analysis (ESI†) indicated 96.3% and 95.2% cell
viability at 100 mM concentrations of the L and D complexes
respectively, for a 24 h loading.
At an initial complex loading concentration of 30 mM, the
images of [EuL1] were not particularly bright due to a self-
quenching eﬀect. Therefore, the experiments were repeated
using much lower concentrations of complex (3 mM). Addi-
tionally, co-staining with LysoTracker Green allowed compar-
ison of the localisation proles of both enantiomers of [EuL1] to
a species known to localise to the lysosomes (Fig. 4). It is evident
that the localisation proles of the enantiomers of [EuL1] are
retained, even at much lower dosing concentrations. Again, the
L-enantiomer appeared to stain the mitochondria while the D-
enantiomer gave predominantly lysosomal staining. These
proles were conrmed by co-staining with LysoTracker Green.
The localisation of D-[EuL1] very closely matched that of Lyso-
Tracker Green, with the RGB colour merge showing almost
exact co-localisation in spherical organelles concentrated
around the nucleus. In contrast, the proles for LysoTracker
Green and L-[EuL1] show weaker correlation, with the complex
emission appearing much more diﬀuse than the lysosomal
localisation of the BODIPY-based stain.
Given that the diﬀerent enantiomers of [EuL1] and [EuL2]
localise in both the mitochondrial network and the lysosomes,
it is perhaps surprising that this cannot be observed in the
images acquired of cells treated with racemic complex. For
example, in Fig. 2, the localisation of the racemic [EuL2] appears
distinctly mitochondrial. However, it should be noted that those
images were recorded aer 4 hours incubation with complex,
rather than aer 24 hours. It is possible, therefore, that both
enantiomers initially localise in the mitochondria, but that the
D-enantiomer moves to the lysosomes faster than the L-enan-
tiomer. Such time-dependent localisation behaviour has been
observed previously for racemic complexes bearing both pyr-
idylarylalkynyl chromophores and azaxanthones.3,4
The sub-cellular localisation behaviour of the closely-related
complex [EuL3] is consistent with this hypothesis.30 Complex
[EuL3] is structurally similar to [EuL2], with one extended
chromophore arm replaced by a 4-methoxy substituted pyridine
moiety. At early time points, L-[EuL3] exhibited localisation
predominantly in the mitochondrial network, conrmed by co-
staining with MitoTracker Green (Fig. 5). In contrast,
Fig. 3 LSCM images of NIH-3T3 cells treated with L-[EuL2] (right) and
D-[EuL2] (left) showing the predominant mitochondrial (P ¼ 0.71) and
lysosomal (P ¼ 0.77) localisation proﬁles respectively (red for Eu emis-
sion, green for Mitotracker Green and LysoTracker Green) (24 h, 20 mM
complex, lexc 355 nm, lem 605–720 nm; for tracker dyes: 0.2 mM, lexc
488 nm, lem 500–530 or 530 to 550 nm). Scale bar ¼ 20 mm.
1046 | Chem. Sci., 2018, 9, 1042–1049 This journal is © The Royal Society of Chemistry 2018
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europium(III) emission from both the tubular networks of the
mitochondria and the circular perinuclear lysosomes was
evident in cells treated with D-[EuL3], suggesting both mito-
chondrial and lysosomal localisation.
Such behaviour is consistent with a time-dependent process.
The complexes are internalised into macropinosomes which, in
such broblast cells are isolated from the endosomal–lysosomal
pathways.10 Therefore, direct traﬃcking of theD-enantiomers to
the lysosomes is unlikely. A more likely hypothesis is that both
enantiomers are transported to the mitochondria and the D-
enantiomer is subsequently traﬃcked to the lysosomes, while
the L-enantiomer remains in the mitochondria.
Macropinosomes are more prone to leakage of their contents
owing to their irregular structure and lack of coating compared
to endocytotic vesicles regulated by clathrin or caveolae. Leakage
of macropinosome content has been observed in A431 epithelial
cells, where uorescent dyes used to label macropinosomes were
found to be distributed throughout the cytosol.31 The cells were
conrmed to be viable as they excluded trypan blue, a dye which
stains only necrotic or apoptotic cells. Indeed, the complexes
described exhibit weak emission from the cytosol, suggesting
that some complex leaks from the macropinosomes.
The mechanisms of intracellular transport of exogenous
molecules are largely ill-dened. It is likely that traﬃcking of the
complexes to their sub-cellular destinations is via vesicular
transport, but the processes that govern the destinations of
diﬀerent complexes are still unknown. Mitochondria are
comprised of two membranes. The inner membrane is perme-
able only to small neutral molecules (oxygen, carbon dioxide and
water) and contains sophisticated transport proteins to facilitate
entry of specic molecules required for aerobic respiration,
which occurs inside the mitochondria. The outer membrane is
similar in composition to the cell surface membrane. Between
the two membranes is the inter-membrane space that is broadly
similar in composition to the cytosol. The outer membrane also
contains porins, which are a family of barrel-shaped proteins
through which large molecules (in some cases up to 5000 Da)
can diﬀuse into the inter-membrane space.32 It is possible that
the europium(III) complexes diﬀuse through these porins and
localise in the inter-membrane space, or that they localise to the
outside of the outer mitochondrial membrane. From here, the
observed localisation proles suggest that the D-enantiomer is
more quickly traﬃcked to the lysosomes than theL-enantiomer.
Since the function of the lysosomes is to chemically degrade
unwanted species using enzymes operating at acidic pH,33 it is
possible that the D-enantiomer is less well tolerated by the cell,
hence is removed to the lysosomes for degradation faster than
the L-enantiomer. Alternatively, it is also possible that the L-
enantiomer preferentially interacts with a species in the mito-
chondria, reducing its rate of transport to the lysosomes.
Summary and conclusions
The primary mechanism of cell uptake of [EuL2] in mouse skin
broblast cells and human breast cancer cells has been
Fig. 4 LSCM images of NIH-3T3 cells treated with L-(left) and D-
(right) [EuL1] (top, 24 h, 3 mM, lexc 355 nm, lem 605–720 nm); Lyso-
Tracker Green (0.2 mM, middle, lexc 488 nm, lem 530–550 nm); and
RGBmerged image (bottom) (PL¼ 0.65, PD¼ 0.79). Scale bar¼ 20 mm.
Fig. 5 LSCM images of NIH-3T3 cells treated with L-[EuL3] and
MitoTracker Green showing both mitochondrial (major) and lysosomal
localisation (left, 8 h, 26 mM, lexc 355 nm, lem 605–720 nm), Mito-
Tracker Green (right, 0.2 mM, lexc 488 nm, lem 500–530 nm) and RGB
merged image (centre); scale bar ¼ 20 mm.
This journal is © The Royal Society of Chemistry 2018 Chem. Sci., 2018, 9, 1042–1049 | 1047
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conrmed to be macropinocytosis, as determined by measuring
complex uptake in the presence of inhibitors and promoters of
various endocytotic pathways.
Using both microscopy and ICP-MS, diﬀerential uptake of
the enantiomers of [EuL1] and [EuL2] has been observed. In the
case of [EuL1], the D-enantiomer is internalised to a greater
extent than the L-enantiomer, whilst for [EuL2] the reverse
behaviour was observed in two diﬀerent cell lines. Titrations of
the enantiomers of [EuL2] with BSA showed varied interactions,
with the L-enantiomer appearing to interact more strongly with
BSA. This behaviour might explain why this enantiomer is
internalised to a greater extent.
The self-quenching behaviour of [EuL1] has been explored,
both in vitro and in cellulo. In cells dosed with 30 mM solutions
of complex, emission was signicantly quenched. Cells dosed
with solutions that were 10 more dilute appeared much
brighter, suggesting that at high concentration, the [EuL1]
complex aggregates, resulting in a quenching of europium(III)
emission.
Comparison of the sub-cellular localisation proles of
enantiopure complexes shows that for both [EuL1] and [EuL2],
the L-enantiomer predominantly localises in the mitochondrial
network, while the D-enantiomer exhibits a predominantly
lysosomal localisation aer 24 h. Similar behaviour was found
for the structurally related complex, [EuL3]. In this case, the D-
enantiomer exhibits both mitochondrial and lysosomal local-
isation at early time points, consistent with a time-dependent
localisation process.
The proposed traﬃcking pathway for these complexes
mirrors that reported earlier for a wide range of cyclen-based
probes,3 involves leakage of the complexes from the macro-
pinosomes into the cytosol, followed by traﬃcking to the
mitochondria. Subsequent removal to the lysosomes for
degradation may occur more quickly for the D-enantiomer.
Whilst the mechanisms by which the complexes are traﬃcked
between various sub-cellular locations remain unknown, there
is unquestionably chiral discrimination in the overall process.
There have been no reports of enantioselective localisation
with rare earth complexes, and only two recent reports of the
enantioselective cellular localisation of any emissive metal
coordination complex. The two enantiomers of certain chiral
ruthenium(II) complexes exhibited slightly diﬀerent localisation
patterns with the D-enantiomer appearing in the cytosol, while
the L-enantiomer seemed to concentrate around the nucleus of
HepG2 cells (human liver cancer cells) and MDA-MB-231 breast
cancer cells.34,35 Toxicity tests with these cationic complexes
showed about 60–70% cell survival at 80 mM dose, aer 24 h.
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